Key facts
- This page summarizes John E. Gallina's Form 4 filing for Elevance Health, Inc. (ELV).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2023, 15:15.
John E. Gallina - 01 Mar 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- ELV
- Reported as of
- 01 Mar 2023
- Net transaction value
- -$2,455,148
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2023, 15:15:27 UTC
- Prior SEC filing
- 03 Mar 2022
- Next SEC filing
- 04 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen S. Kiefer, Attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Gallina filed Form 4 for Elevance Health, Inc. (ELV) on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 03 Mar 2022.
- Current net transaction value: -$2,455,148.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELV
transaction
Common Stock
Tax liability
- Transaction value
- $275,321
- Shares
- -587
- Change %
- -1%
- Price
- $469.03
- Shares after
- 55,594
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
ELV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,065
- Change %
- +5.5%
- Price
- $0.000000
- Shares after
- 58,659
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
ELV
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +9,716
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 68,375
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F3
ELV
transaction
Common Stock
Tax liability
- Transaction value
- $2,179,827
- Shares
- -4,650
- Change %
- -6.8%
- Price
- $468.78
- Shares after
- 63,725
- Date
- 02 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELV
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +11,782
- Change %
- Price
- $0.000000
- Shares after
- 11,782
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,782
- Exercise price
- $469.03
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2
Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.
Footnote F3
Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
Footnote F4
The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.